An SHIV DNA/MVA Rectal Vaccination in Macaques Provides Systemic and Mucosal Virus-Specific Responses and Protection against AIDS-Reference-Cited by-同舟云学术

An SHIV DNA/MVA Rectal Vaccination in Macaques Provides Systemic and Mucosal Virus-Specific Responses and Protection against AIDS

Published:2004-08 Issue:8 Volume:20 Page:846-859
ISSN:0889-2229
Container-title:AIDS Research and Human Retroviruses
language:en
Short-container-title:AIDS Research and Human Retroviruses

Author:

Wang Shainn-Wei¹,Bertley Frederic M.N.¹,Kozlowski Pamela A.¹,Herrmann Lara¹,Manson Kelledy²,Mazzara Gail²,Piatak Mike³,Johnson R. Paul⁴,Carville Angela⁵,Mansfield Keith⁵,Aldovini Anna¹

Affiliation:

1. Department of Medicine, Children's Hospital, and Department of Pediatrics, Harvard Medical School, Boston, Massachusetts 02115.

2. Therion, Cambridge, Massachusetts 02142.

3. Retroviral Pathogenesis Laboratory, AIDS Vaccine Program, SAIC Frederick, NCI-FCRDC, Frederick, Maryland 21702.

4. New England Primate Research Center, Harvard Medical School, Southborough, Massachusetts 01772; Partners for AIDS Research Center and Infectious Disease Unit, Massachusetts General Hospital, Charlestown, Massachusetts 02129.

5. New England Primate Research Center, Harvard Medical School, Southborough, Massachusetts 01772.

Publisher

Mary Ann Liebert Inc

Subject

Infectious Diseases,Virology,Immunology

Link

http://www.liebertpub.com/doi/pdf/10.1089/0889222041725253

Reference80 articles.

1. New hope for an aids vaccine

2. CD8 + Lymphocytes Can Control HIV Infection in Vitro by Suppressing Virus Replication

3. Virus-specific CD8+ cytotoxic T-lymphocyte activity associated with control of viremia in primary human immunodeficiency virus type 1 infection

4. Cytotoxic-T-Cell Responses, Viral Load, and Disease Progression in Early Human Immunodeficiency Virus Type 1 Infection

5. Quantitation of HIV-1-Specific Cytotoxic T Lymphocytes and Plasma Load of Viral RNA

Cited by 44 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Particulate antigens administrated by intranasal and intravaginal routes in a prime-boost strategy improve HIV-specific TFH generation, high-quality antibodies and long-lasting mucosal immunity;European Journal of Pharmaceutics and Biopharmaceutics;2023-10

2. Immunization by exposure to live virus (SIVmne/HIV-2287) during antiretroviral drug prophylaxis may reduce risk of subsequent viral challenge;PLOS ONE;2021-04-29

3. Immunization by exposure to live virus (SIVmne/HIV-2287) during antiretroviral drug prophylaxis reduces risk of subsequent viral challenge;2020-10-01

4. Mucosal Vaccine Approaches for Prevention of HIV and SIV Transmission;Current Immunology Reviews;2019-04-12

5. DNA Vaccine–Induced Long-Lasting Cytotoxic T Cells Targeting Conserved Elements of Human Immunodeficiency Virus Gag Are Boosted Upon DNA or Recombinant Modified Vaccinia Ankara Vaccination;Human Gene Therapy;2018-09